Optogenetic cell control in experimental models of neurological disorders.
Identifieur interne : 001177 ( Ncbi/Checkpoint ); précédent : 001176; suivant : 001178Optogenetic cell control in experimental models of neurological disorders.
Auteurs : Jan T Nnesen [France]Source :
- Behavioural brain research [ 1872-7549 ] ; 2013.
English descriptors
- KwdEn :
- MESH :
- methods : Optogenetics.
- pathology : Brain, Nervous System Diseases.
- physiology : Brain, Neurons.
- physiopathology : Nervous System Diseases.
- therapy : Nervous System Diseases.
- Animals, Disease Models, Animal.
Abstract
The complexity of the brain, in which different neuronal cell types are interspersed and complexly interconnected, has posed a major obstacle in identifying pathophysiological mechanisms underlying prevalent neurological disorders. This is largely based in the inability of classical experimental approaches to target defined neural populations at sufficient temporal and spatial resolution. As a consequence, effective clinical therapies for prevalent neurological disorders are largely lacking. Recently developed optogenetic probes are genetically expressed photosensitive ion channels and pumps that in principal overcome these limitations. Optogenetic probes allow millisecond resolution functional control over selected optogenetically transduced neuronal populations targeted based on promoter activity. This optical cell control scheme has already been applied to answer fundamental questions pertaining to neurological disorders by allowing researchers to experimentally intercept, or induce, pathophysiological neuronal signaling activity in a highly controlled manner. Offering high temporal resolution control over neural activity at high cellular specificity, optogenetic tools constitute a game changer in research aiming at understanding pathophysiological signaling mechanisms in neurological disorders and in developing therapeutic strategies to correct these. In this regard, recent experimental work has provided new insights in underlying mechanisms, as well as preliminary proof-of-principle for optogenetic therapies, of several neurological disorders, including Parkinson's disease, epilepsy and progressive blindness. This review synthesizes experimental work where optogenetic tools have been applied to explore pathologic neural network activity in models of neurological disorders.
DOI: 10.1016/j.bbr.2013.07.007
PubMed: 23871610
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000675
- to stream PubMed, to step Curation: 000647
- to stream PubMed, to step Checkpoint: 000647
- to stream Ncbi, to step Merge: 001177
- to stream Ncbi, to step Curation: 001177
Links to Exploration step
pubmed:23871610Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Optogenetic cell control in experimental models of neurological disorders.</title>
<author><name sortKey="T Nnesen, Jan" sort="T Nnesen, Jan" uniqKey="T Nnesen J" first="Jan" last="T Nnesen">Jan T Nnesen</name>
<affiliation wicri:level="3"><nlm:affiliation>Experimental Epilepsy Group, Division of Neurology, Wallenberg Neuroscience Center, Lund University Hospital, Lund, Sweden; Synaptic Plasticity and Superresolution Microscopy Group, Interdisciplinary Institute for Neuroscience and UMR 5297 CNRS/Université Bordeaux Segalen, Bordeaux, France. Electronic address: jan.tonnesen@u-bordeaux2.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Experimental Epilepsy Group, Division of Neurology, Wallenberg Neuroscience Center, Lund University Hospital, Lund, Sweden; Synaptic Plasticity and Superresolution Microscopy Group, Interdisciplinary Institute for Neuroscience and UMR 5297 CNRS/Université Bordeaux Segalen, Bordeaux</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23871610</idno>
<idno type="pmid">23871610</idno>
<idno type="doi">10.1016/j.bbr.2013.07.007</idno>
<idno type="wicri:Area/PubMed/Corpus">000675</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000675</idno>
<idno type="wicri:Area/PubMed/Curation">000647</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000647</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000647</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000647</idno>
<idno type="wicri:Area/Ncbi/Merge">001177</idno>
<idno type="wicri:Area/Ncbi/Curation">001177</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001177</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Optogenetic cell control in experimental models of neurological disorders.</title>
<author><name sortKey="T Nnesen, Jan" sort="T Nnesen, Jan" uniqKey="T Nnesen J" first="Jan" last="T Nnesen">Jan T Nnesen</name>
<affiliation wicri:level="3"><nlm:affiliation>Experimental Epilepsy Group, Division of Neurology, Wallenberg Neuroscience Center, Lund University Hospital, Lund, Sweden; Synaptic Plasticity and Superresolution Microscopy Group, Interdisciplinary Institute for Neuroscience and UMR 5297 CNRS/Université Bordeaux Segalen, Bordeaux, France. Electronic address: jan.tonnesen@u-bordeaux2.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Experimental Epilepsy Group, Division of Neurology, Wallenberg Neuroscience Center, Lund University Hospital, Lund, Sweden; Synaptic Plasticity and Superresolution Microscopy Group, Interdisciplinary Institute for Neuroscience and UMR 5297 CNRS/Université Bordeaux Segalen, Bordeaux</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Behavioural brain research</title>
<idno type="eISSN">1872-7549</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Brain (pathology)</term>
<term>Brain (physiology)</term>
<term>Disease Models, Animal</term>
<term>Nervous System Diseases (pathology)</term>
<term>Nervous System Diseases (physiopathology)</term>
<term>Nervous System Diseases (therapy)</term>
<term>Neurons (physiology)</term>
<term>Optogenetics (methods)</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Optogenetics</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Brain</term>
<term>Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Brain</term>
<term>Neurons</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The complexity of the brain, in which different neuronal cell types are interspersed and complexly interconnected, has posed a major obstacle in identifying pathophysiological mechanisms underlying prevalent neurological disorders. This is largely based in the inability of classical experimental approaches to target defined neural populations at sufficient temporal and spatial resolution. As a consequence, effective clinical therapies for prevalent neurological disorders are largely lacking. Recently developed optogenetic probes are genetically expressed photosensitive ion channels and pumps that in principal overcome these limitations. Optogenetic probes allow millisecond resolution functional control over selected optogenetically transduced neuronal populations targeted based on promoter activity. This optical cell control scheme has already been applied to answer fundamental questions pertaining to neurological disorders by allowing researchers to experimentally intercept, or induce, pathophysiological neuronal signaling activity in a highly controlled manner. Offering high temporal resolution control over neural activity at high cellular specificity, optogenetic tools constitute a game changer in research aiming at understanding pathophysiological signaling mechanisms in neurological disorders and in developing therapeutic strategies to correct these. In this regard, recent experimental work has provided new insights in underlying mechanisms, as well as preliminary proof-of-principle for optogenetic therapies, of several neurological disorders, including Parkinson's disease, epilepsy and progressive blindness. This review synthesizes experimental work where optogenetic tools have been applied to explore pathologic neural network activity in models of neurological disorders.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Aquitaine</li>
<li>Nouvelle-Aquitaine</li>
</region>
<settlement><li>Bordeaux</li>
</settlement>
</list>
<tree><country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="T Nnesen, Jan" sort="T Nnesen, Jan" uniqKey="T Nnesen J" first="Jan" last="T Nnesen">Jan T Nnesen</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001177 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 001177 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:23871610 |texte= Optogenetic cell control in experimental models of neurological disorders. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:23871610" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
![]() | This area was generated with Dilib version V0.6.29. | ![]() |